A study of "Tocilizumab treated convalescent COVID-19 patients retain the cross-neutralization potential against SARS-CoV-2 variants". Chauvin et al
收藏Mendeley Data2026-04-09 收录
下载链接：
https://data.mendeley.com/datasets/krh7cy99wg
下载链接
链接失效反馈官方服务：
资源简介：
Supplementary Dataset for the manuscript "Tocilizumab treated convalescent COVID-19 patients retain the cross-neutralization potential against SARS-CoV-2 variants". Description of each patient according to disease severity and treatment. 55 out of 69 patients were recruited during the first COVID-19 wave while 14 patients were recruited during the second/third wave of COVID-19.
